Moving Oral SERDs into the Adjuvant Setting: Insights from the lidERA Trial with Drs. Mchayleh & Jhaveri

From Podium To Practice Drs. Wassim Mchayleh and Komal Jhaveri review the phase 3 lidERA trial, which evaluated the oral SERD giredes...
Read More
Moving Oral SERDs into the Adjuvant Setting: Insights from the lidERA Trial with Drs. Mchayleh & Jhaveri

Latest Videos

Drs. Wassim Mchayleh & Komal Jhaveri Discuss the evERA Trial in ER+ Metastatic Breast Cancer

Drs. Wassim Mchayleh & Komal Jhaveri Discuss the evERA Trial in ER+ Metastatic Breast Cancer

From Podium To Practice Drs. Wassim Mchayleh and Komal Jhaveri review the evERA trial, which evaluated the oral SERD giredestrant com...
Watch Now
Drs. Wassim Mchayleh & Komal Jhaveri: EMBER-3 Trial Insights

Drs. Wassim Mchayleh & Komal Jhaveri: EMBER-3 Trial Insights

From Podium To Practice Drs. Wassim Mchayleh and Komal Jhaveri discuss the EMBER-3 trial evaluating the oral SERD imlunestrant in pat...
Watch Now
Dr. Wassim Mchayleh on ASCENT-03: Evaluating Sacituzumab Govitecan in HR+/HER2- Metastatic Breast Cancer

Dr. Wassim Mchayleh on ASCENT-03: Evaluating Sacituzumab Govitecan in HR+/HER2- Metastatic Breast Cancer

From Podium To Practice – Breast Cancer ESMO Part 1 In this overview, Dr. Wassim Mchayleh breaks down the ASCENT-03 trial, high...
Watch Now
Dr. Wassim Mchayleh on TROPION-Breast02: Evaluating Dato-DxD in Metastatic Breast Cancer

Dr. Wassim Mchayleh on TROPION-Breast02: Evaluating Dato-DxD in Metastatic Breast Cancer

From Podium To Practice – Breast Cancer ESMO Part 2 In this segment, Dr. Wassim Mchayleh reviews the design and objectives of T...
Watch Now
Dr. Wassim Mchayleh on VIKTORIA-1: Gedatolisib Combinations in HR+/HER2- Metastatic Breast Cancer

Dr. Wassim Mchayleh on VIKTORIA-1: Gedatolisib Combinations in HR+/HER2- Metastatic Breast Cancer

From Podium To Practice – Breast Cancer ESMO Part 3 In this overview, Dr. Wassim Mchayleh explains the design and significance ...
Watch Now
Dr. Wassim Mchayleh on evERA: Exploring Elacestrant Combinations in ER+/HER2– Metastatic Breast Cancer

Dr. Wassim Mchayleh on evERA: Exploring Elacestrant Combinations in ER+/HER2– Metastatic Breast Cancer

From Podium To Practice – Breast Cancer ESMO Part 4 In this overview, Dr. Wassim Mchayleh breaks down the evERA trial, which ev...
Watch Now
Dr. Sara Tolaney & Dr. Wassim Mchayleh on Trial Design & Patient Populations in ASCENT-03 and TROPION-Breast02

Dr. Sara Tolaney & Dr. Wassim Mchayleh on Trial Design & Patient Populations in ASCENT-03 and TROPION-Breast02

From Podium To Practice – Breast Cancer ESMO Part 5 In this discussion, Dr. Wassim Mchayleh of AdventHealth introduces Dr. Sara...
Watch Now
Interpreting Efficacy & Ethical Design: Drs. Tolaney and Mchayleh on ORR, PFS, OS & Crossover Strategy

Interpreting Efficacy & Ethical Design: Drs. Tolaney and Mchayleh on ORR, PFS, OS & Crossover Strategy

From Podium To Practice – Breast Cancer ESMO Part 6 In this discussion, Dr. Wassim Mchayleh and Dr. Sara Tolaney dissect the ef...
Watch Now